EyeBio

Merck and EyeBio launch trial of Restoret for diabetic macular edema
Clinical Trials Arena
Thu, 09/5/24 - 11:33 am
Merck
EyeBio
diabetic macular edema
diabetes
Restoret
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
M&A
Merck
EyeBio
JNJ
Numab Therapeutics
Asahi Kasei
Calliditas Therapeutics
Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
EyeBio raises $65m in Series A round: ‘Our goal is to build a broad and diverse pipeline of therapies for the eye’
Biopharma Reporter
Wed, 03/2/22 - 09:56 am
EyeBio
funding
eye health